Profil
Catherine Hu worked as a Director of Investor Relations at Alexion Pharmaceuticals, Inc. She then worked as an Executive Director of Investor Relations and Corporate Communications at Scholar Rock Holding Corp.
from 2018 to 2021.
Ms. Hu received an undergraduate degree from The Leonard N Stern School of Business.
Ehemalige bekannte Positionen von Catherine Hu
| Unternehmen | Position | Ende |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Investor Relations Kontakt | 01.10.2021 |
| ALEXION PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Ausbildung von Catherine Hu
| The Leonard N Stern School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |